9
views
0
recommends
+1 Recommend
2 collections
    0
    shares

          The flagship journal of the Society for Endocrinology. Learn more

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Osmotic demyelination syndrome in a patient with Noonan syndrome and anterior hypopituitarism

      research-article
      1 , 1
      Endocrinology, Diabetes & Metabolism Case Reports
      Bioscientifica Ltd
      Adult, Male, Asian - other, Singapore, Pituitary, Pituitary, GH, Thyroxine (T4), Triiodothyronine (T3), TSH, Cortisol, ACTH, FSH, LH, Testosterone, IGF1, Noonan syndrome, Hypopituitarism, Hyponatraemia, Pituitary adenoma, Microadenoma, Hypopituitarism, Hyponatraemia, Dizziness, Headache, Insomnia, Nausea, Abdominal pain, Vomiting, Hypotension, Kyphoscoliosis, Gynaecomastia, Ears - low set, Neck - short, Hypogonadism, Short stature, Neck - loose skin (nape), Hypothyroidism, Seizures, Hypotonia, Aphasia, Osteoporosis, Sodium, MRI, Blood pressure, Serum osmolality, Urine osmolality, GH, FT3, FT4, TSH, Cortisol, Cortisol (9am), Cortisol (serum), ACTH, FSH, LH, Testosterone, IGF1, Bone mineral density, X-ray, Chloride, Haemoglobin , 25-hydroxyvitamin-D3, Sex hormone binding globulin, Fluid repletion, Saline, Hydrocortisone, Glucocorticoids, Glucose, Desmopressin, Levothyroxine, Valproic acid, Neurology, Unique/unexpected symptoms or presentations of a disease, August, 2020

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Summary

          Severe hyponatremia and osmotic demyelination syndrome (ODS) are opposite ends of a spectrum of emergency disorders related to sodium concentrations. Management of severe hyponatremia is challenging because of the difficulty in balancing the risk of overcorrection leading to ODS as well as under-correction causing cerebral oedema, particularly in a patient with chronic hypocortisolism and hypothyroidism. We report a case of a patient with Noonan syndrome and untreated anterior hypopituitarism who presented with symptomatic hyponatremia and developed transient ODS.

          Learning points:
          • Patients with severe anterior hypopituitarism with severe hyponatremia are susceptible to the rapid rise of sodium level with a small amount of fluid and hydrocortisone.

          • These patients with chronic anterior hypopituitarism are at high risk of developing ODS and therefore, care should be taken to avoid a rise of more than 4–6 mmol/L per day.

          • Early recognition and rescue desmopressin and i.v. dextrose 5% fluids to reduce serum sodium concentration may be helpful in treating acute ODS.

          Related collections

          Most cited references14

          • Record: found
          • Abstract: found
          • Article: not found

          Osmotic demyelination syndrome following correction of hyponatremia.

          The treatment of hyponatremia is controversial: some authorities have cautioned that rapid correction causes central pontine myelinolysis, and others warn that severe hyponatremia has a high mortality rate unless it is corrected rapidly. Eight patients treated over a five-year period at our two institutions had a neurologic syndrome with clinical or pathological findings typical of central pontine myelinolysis, which developed after the patients presented with severe hyponatremia. Each patient's condition worsened after relatively rapid correction of hyponatremia (greater than 12 mmol of sodium per liter per day)--a phenomenon that we have called the osmotic demyelination syndrome. Five of the patients were treated at one hospital, and accounted for all the neurologic complications recorded among 60 patients with serum sodium concentrations below 116 mmol per liter; no patient in whom the sodium level was raised by less than 12 mmol per liter per day had any neurologic sequelae. Reviewing published reports on patients with very severe hyponatremia (serum sodium less than 106 mmol per liter) revealed that neurologic sequelae were associated with correction of hyponatremia by more than 12 mmol per liter per day; when correction proceeded more slowly, patients had uneventful recoveries. We suggest that the osmotic demyelination syndrome is a preventable complication of overly rapid correction of chronic hyponatremia.
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Diagnosis and treatment of hyponatremia: a systematic review of clinical practice guidelines and consensus statements

            Background Hyponatremia is a common electrolyte disorder. Multiple organizations have published guidance documents to assist clinicians in managing hyponatremia. We aimed to explore the scope, content, and consistency of these documents. Methods We searched MEDLINE, EMBASE, and websites of guideline organizations and professional societies to September 2014 without language restriction for Clinical Practice Guidelines (defined as any document providing guidance informed by systematic literature review) and Consensus Statements (any other guidance document) developed specifically to guide differential diagnosis or treatment of hyponatremia. Four reviewers appraised guideline quality using the 23-item AGREE II instrument, which rates reporting of the guidance development process across six domains: scope and purpose, stakeholder involvement, rigor of development, clarity of presentation, applicability, and editorial independence. Total scores were calculated as standardized averages by domain. Results We found ten guidance documents; five clinical practice guidelines and five consensus statements. Overall, quality was mixed: two clinical practice guidelines attained an average score of >50% for all of the domains, three rated the evidence in a systematic way and two graded strength of the recommendations. All five consensus statements received AGREE scores below 60% for each of the specific domains. The guidance documents varied widely in scope. All dealt with therapy and seven included recommendations on diagnosis, using serum osmolality to confirm hypotonic hyponatremia, and volume status, urinary sodium concentration, and urinary osmolality for further classification of the hyponatremia. They differed, however, in classification thresholds, what additional tests to consider, and when to initiate diagnostic work-up. Eight guidance documents advocated hypertonic NaCl in severely symptomatic, acute onset ( 48 h) or asymptomatic cases, recommended treatments were NaCl 0.9%, fluid restriction, and cause-specific therapy for hypovolemic, euvolemic, and hypervolemic hyponatremia, respectively. Eight guidance documents recommended limits for speed of increase of sodium concentration, but these varied between 8 and 12 mmol/L per 24 h. Inconsistencies also existed in the recommended dose of NaCl, its initial infusion speed, and which second line interventions to consider. Conclusions Current guidance documents on the assessment and treatment of hyponatremia vary in methodological rigor and recommendations are not always consistent. Electronic supplementary material The online version of this article (doi:10.1186/s12916-014-0231-1) contains supplementary material, which is available to authorized users.
              • Record: found
              • Abstract: not found
              • Article: not found

              Desmopressin to Prevent Rapid Sodium Correction in Severe Hyponatremia: A Systematic Review

                Author and article information

                Journal
                Endocrinol Diabetes Metab Case Rep
                Endocrinol Diabetes Metab Case Rep
                EDM
                Endocrinology, Diabetes & Metabolism Case Reports
                Bioscientifica Ltd (Bristol )
                2052-0573
                20 August 2020
                2020
                : 2020
                : 20-0039
                Affiliations
                [1 ]Department of Endocrinology , Changi General Hospital, Singapore
                Author notes
                Correspondence should be addressed to T Chua; Email: tzyharn.chua@ 123456mohh.com.sg
                Article
                EDM200039
                10.1530/EDM-20-0039
                7487176
                e17a2cfe-21f2-47a1-b148-1053731d67f0
                © 2020 The authors

                This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License..

                History
                : 18 May 2020
                : 29 July 2020
                Categories
                Adult
                Male
                Asian - Other
                Singapore
                Pituitary
                Pituitary
                GH
                Thyroxine (T4)
                Triiodothyronine (T3)
                TSH
                Cortisol
                ACTH
                FSH
                LH
                Testosterone
                IGF1
                Noonan syndrome
                Hypopituitarism
                Hyponatraemia
                Pituitary adenoma
                Microadenoma
                Hypopituitarism
                Hyponatraemia
                Dizziness
                Headache
                Insomnia
                Nausea
                Abdominal pain
                Vomiting
                Hypotension
                Kyphoscoliosis
                Gynaecomastia
                Ears - low set
                Neck - short
                Hypogonadism
                Short stature
                Neck - loose skin (nape)
                Hypothyroidism
                Seizures
                Hypotonia
                Aphasia
                Osteoporosis
                Sodium
                MRI
                Blood pressure
                Serum osmolality
                Urine osmolality
                GH
                FT3
                FT4
                TSH
                Cortisol
                Cortisol (9am)
                Cortisol (serum)
                ACTH
                FSH
                LH
                Testosterone
                IGF1
                Bone mineral density
                X-ray
                Chloride
                Haemoglobin
                25-hydroxyvitamin-D3
                Sex hormone binding globulin
                Fluid repletion
                Saline
                Hydrocortisone
                Glucocorticoids
                Glucose
                Desmopressin
                Levothyroxine
                Valproic acid
                Neurology
                Unique/Unexpected Symptoms or Presentations of a Disease
                Unique/Unexpected Symptoms or Presentations of a Disease

                adult,male,asian - other,singapore,pituitary,gh,thyroxine (t4),triiodothyronine (t3),tsh,cortisol,acth,fsh,lh,testosterone,igf1,noonan syndrome,hypopituitarism,hyponatraemia,pituitary adenoma,microadenoma,dizziness,headache,insomnia,nausea,abdominal pain,vomiting,hypotension,kyphoscoliosis,gynaecomastia,ears - low set,neck - short,hypogonadism,short stature,neck - loose skin (nape),hypothyroidism,seizures,hypotonia,aphasia,osteoporosis,sodium,mri,blood pressure,serum osmolality,urine osmolality,ft3,ft4,cortisol (9am),cortisol (serum),bone mineral density,x-ray,chloride,haemoglobin ,25-hydroxyvitamin-d3,sex hormone binding globulin,fluid repletion,saline,hydrocortisone,glucocorticoids,glucose,desmopressin,levothyroxine,valproic acid,neurology,unique/unexpected symptoms or presentations of a disease,august,2020

                Comments

                Comment on this article

                Related Documents Log